Early Phase Solutions
We can provide experts in Data Management, Biostatistics, Statistical Programming, Medical Writing who can identify product value quickly and precisely, giving your clinical trial the best chance to prove its value.
Understanding the Potential of New Therapies
At Cytel, we are known for our proficiency in clinical trial biometrics solutions, and are experienced developers of statistical software and operational tools which can solve an array of early-phase clinical trial challenges.
Our clinical trial implementation teams are trained to work with a variety of dose-escalation designs, including both rule-based and model-based dose-escalation designs. These designs have been shown to be superior to the classic “3+3” design, and allow the identification of an optimal dose range for Phase 2.
Our high-efficiency clinical trial experts have worked across multiple therapeutic areas. When issues arise during an early-phase clinical trial, we have the industry experience to be responsive to challenges as they arise, as well as to spot novel opportunities for early-phase trials.
Cytel’s early-phase teams have the advanced expertise to work with both Bayesian and Frequentist designs, initiate learning through small sample datasets, and make clinical data easily accessible to both a sponsor’s study team and trial clinicians.
Intelligence
Use traditional and novel early-phase dose-escalation techniques that match your clinical operations needs.
Confidence
Statistical insight delivered with speed and operating procedures designed for the curation of quality clinical data.